uracil has been researched along with Kidney Neoplasms in 61 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Kidney Neoplasms: Tumors or cancers of the KIDNEY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The safety of prolonged administration of UFT in which tegafur and uracil were mixed in a ratio of 1:4 in molar fraction was studied in 44 cases of bladder cancer and 10 cases of renal cell carcinoma." | 7.67 | [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma]. ( Fujioka, Y; Hirasawa, S; Ishii, Y; Ito, H; Lin, TT; Nakagami, Y; Ogawa, H; Tanaka, K; Tannawa, K; Yamada, N, 1987) |
| " UFT (a compound of tegafur and uracil) is said to be effective for bladder cancer." | 4.80 | [Progress in oral anti-cancer drug therapy for urological cancer]. ( Akaza, H; Tsukamoto, S, 1999) |
| " Using a murine dorsal air sac (DAS) assay, we have previously shown that UFT and its metabolites, gamma-hydroxybutyric acid (GHB) and 5-fluorouracil (5-FU), inhibited the angiogenesis induced by murine renal cell carcinoma." | 3.71 | gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor. ( Aoyagi, K; Basaki, Y; Chikahisa, L; Hashimoto, A; Miyadera, K; Okabe, S; Wierzba, K; Yamada, Y; Yonekura, K, 2001) |
| "The safety of prolonged administration of UFT in which tegafur and uracil were mixed in a ratio of 1:4 in molar fraction was studied in 44 cases of bladder cancer and 10 cases of renal cell carcinoma." | 3.67 | [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma]. ( Fujioka, Y; Hirasawa, S; Ishii, Y; Ito, H; Lin, TT; Nakagami, Y; Ogawa, H; Tanaka, K; Tannawa, K; Yamada, N, 1987) |
| "In urinary bladder cancer, the combination chemotherapy with 5-FU and low-dose CDDP has been used as a radiosensitizer." | 2.40 | [Combination chemotherapy with 5-FU and low-dose CDDP for urogenital tumors]. ( Fujinami, K; Kubota, Y, 1999) |
| "The pathological diagnosis was renal cell carcinoma, clear cell type, grade 1, pT3bNxMx stage III." | 1.36 | [Tegafur-uracil markedly reduced pulmonary metastasis from renal cell carcinoma refractory to sorafenib, interferon and interleukin 2]. ( Homma, Y; Kaneko, T; Matsushima, H; Morimoto, H; Tsuzaka, Y, 2010) |
| "We report two cases of squamous cell carcinoma of upper urinary tract with hypercalcemia." | 1.35 | [Two cases of squamous cell carcinoma of upper urinary tract with hypercalcemia]. ( Kobayashi, Y; Matsuzaki, A; Terauchi, F; Washino, S, 2008) |
| "A 73-year-old man with renal cell carcinoma involving the left renal vein was treated with the embolization of the left renal artery followed by interferon-alpha and UFT." | 1.30 | [Tumor reduction in advanced renal cell carcinoma with tumor thrombus by renal embolization, interferon-alpha and UFT. A case report]. ( Hamaguchi, K; Kamura, K; Matsushita, K; Seto, K; Shiomi, K; Yamauchi, T, 1997) |
| "A 60-year-old man with renal cell carcinoma and metastases to the right 7th rib and L2 vertebra (T2N0M1, OSS) was treated with interferon-alpha and the uracil and tegafur combination following nephrectomy." | 1.29 | A case of posttherapeutic sclerotic change of bone metastasis from renal cell carcinoma which proved histopathologically to be complete response. ( Maehara, Y; Satoh, J; Shibata, Y; Shimizu, TS; Sugihara, S; Uchida, T, 1994) |
| "We report a case of renal cell carcinoma in a 76-year-old man with pulmonary metastasis and tumor thrombus in inferior vena cava." | 1.29 | [Successful management for advanced renal cell carcinoma under combination therapy with human lymphoblastoid interferon-alpha and UFT (mixture of tegafur and uracil): a case report]. ( Kanno, H; Kitami, K; Nagashima, Y; Senga, Y; Takahashi, T, 1993) |
| "This is a rare case of renal cell carcinoma with local recurrence and lung metastasis successfully treated with UFT." | 1.28 | [A case of renal cell carcinoma with lung metastasis and local recurrence effectively treated with nephrectomy and UFT]. ( Matsuda, M; Taguchi, H; Takaoka, K, 1992) |
| "Uracil was administered for 15, 10 or 5 weeks followed by BBN for 23 weeks, the total observation time being 40 weeks." | 1.28 | Lack of synergism in rat urinary tract carcinogenesis between prior uracil treatment and N-butyl-N-(4-hydroxybutyl)-nitrosamine administration. ( Asamoto, M; Fukushima, S; Ogiso, T; Okumura, M; Shirai, T, 1991) |
| "He was diagnosed as having right renal cell carcinoma which had metastasized to the lung." | 1.28 | [A case of recurrence of a metastatic brain tumor which disappeared due to chemotherapy only]. ( Kayama, T; Ogawa, A; Sakurai, Y; Sato, K; Wada, T, 1990) |
| "Eighty patients of renal cell carcinoma were treated during the period." | 1.28 | [Therapy on pulmonary metastasis of renal cell carcinoma]. ( Akimoto, M; Hara, M; Hasegawa, J; Kawamura, N, 1990) |
| "The authors have monitored a case of renal cell carcinoma metastatic to the supraclavicular cavity over a twenty-year period following surgical removal of a cancerous kidney." | 1.27 | [A case report of successful immunochemotherapy of metastatic renal cell carcinoma using UFT and PSK]. ( Hongo, H; Ishizu, K; Kondo, N; Kurata, S; Kuroda, Y; Misumi, K; Nakayasu, K; Ohfuji, K; Shinagawa, H, 1987) |
| "A case of multiple lung metastasis of renal cell carcinoma in which complete remission was obtained with administration of UFT (Tegafur + Uracil) is reported." | 1.27 | [Complete remission of lung metastasis of renal cell carcinoma by (UFT) therapy]. ( Fukushima, S; Sakuramoto, T; Sugawara, T, 1987) |
| "A rare case of metastatic renal cell carcinoma which represented complete remission by chemotherapy and surgical treatment is presented." | 1.27 | [Complete remission of advanced renal cell carcinoma by chemotherapy and surgical treatment: a case report]. ( Fukuoka, H; Goto, A; Kitamura, H; Murai, T, 1987) |
| " Moreover, intratumoral concentration of 5-FU differed markedly even with the same administration method and dosage level." | 1.27 | [Anti-tumour effect of UFT on human renal cell carcinoma heterotransplanted into nude mice]. ( Furuta, M; Iizuka, N; Kondo, I; Machida, T; Masuda, F; Mori, Y; Nakada, J; Onishi, T; Suzuki, M, 1988) |
| "Fifteen cases with advanced cancer were treated with UFD-1 (mixture of FD-1 and uracil under molar ratio of 1: 20) in a daily dose of 300 mg of FD-1." | 1.26 | [Clinical experiences with UFD-1]. ( Furue, H, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (34.43) | 18.7374 |
| 1990's | 29 (47.54) | 18.2507 |
| 2000's | 9 (14.75) | 29.6817 |
| 2010's | 2 (3.28) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watanabe, Y | 3 |
| Kobayashi, M | 3 |
| Ikeda, H | 1 |
| Nukui, A | 2 |
| Suzuki, K | 2 |
| Sugaya, Y | 2 |
| Yuzawa, M | 1 |
| Morita, T | 2 |
| Washino, S | 1 |
| Terauchi, F | 1 |
| Matsuzaki, A | 1 |
| Kobayashi, Y | 1 |
| Morimoto, H | 1 |
| Tsuzaka, Y | 1 |
| Kaneko, T | 1 |
| Matsushima, H | 1 |
| Homma, Y | 2 |
| Mitsuhata, N | 1 |
| Ito, S | 1 |
| Hoshi, K | 1 |
| Kanbara, T | 1 |
| Kawasaki, Y | 1 |
| Ikeda, Y | 1 |
| Namima, T | 1 |
| Ohnuma, T | 1 |
| Masuda, F | 9 |
| Arai, Y | 1 |
| Tashiro, K | 1 |
| Machida, T | 5 |
| Shida, K | 1 |
| Yamanaka, H | 2 |
| Ito, Y | 1 |
| Shimazaki, J | 1 |
| Isaka, S | 1 |
| Yokokawa, M | 1 |
| Fukui, I | 1 |
| Kawai, H | 1 |
| Akimoto, M | 2 |
| Yoshida, K | 1 |
| Furue, H | 1 |
| Yamada, Y | 9 |
| Fukatsu, H | 2 |
| Honda, N | 2 |
| Miyagawa, Y | 1 |
| Segawa, A | 2 |
| Shimizu, TS | 1 |
| Uchida, T | 1 |
| Shibata, Y | 1 |
| Satoh, J | 1 |
| Sugihara, S | 1 |
| Maehara, Y | 1 |
| Takashi, M | 2 |
| Sakata, T | 2 |
| Nakano, Y | 2 |
| Takagi, Y | 2 |
| Hibi, H | 2 |
| Miyake, K | 2 |
| Shirai, T | 3 |
| Esteban, E | 1 |
| Buesa, JM | 1 |
| Cueva, J | 1 |
| Fernández, Y | 1 |
| Peláez, I | 1 |
| Fernández, JL | 1 |
| Sanz, A | 1 |
| Palacio, I | 1 |
| Estrada, E | 1 |
| Gracia, JM | 1 |
| Shibata, MA | 1 |
| Sano, M | 1 |
| Imaida, K | 1 |
| Fukushima, S | 3 |
| Kanno, H | 1 |
| Kitami, K | 1 |
| Senga, Y | 1 |
| Takahashi, T | 1 |
| Nagashima, Y | 1 |
| Terachi, T | 1 |
| Okada, Y | 1 |
| Takeuchi, H | 1 |
| Yoshida, O | 1 |
| Shiomi, K | 1 |
| Kamura, K | 1 |
| Seto, K | 1 |
| Hamaguchi, K | 1 |
| Matsushita, K | 1 |
| Yamauchi, T | 1 |
| Naito, S | 1 |
| Kumazawa, J | 2 |
| Omoto, T | 1 |
| Iguchi, A | 1 |
| Sagiyama, K | 2 |
| Osada, Y | 1 |
| Hiratsuka, Y | 1 |
| Miyagi, T | 1 |
| Fuse, H | 1 |
| Uchibayashi, T | 1 |
| Namiki, M | 1 |
| Oda, M | 1 |
| Mizukami, Y | 1 |
| Uehara, T | 1 |
| Yano, T | 1 |
| Kanematsu, T | 1 |
| Terazaki, Y | 1 |
| Kuninaka, S | 1 |
| Fukuyama, Y | 1 |
| Yokoyama, H | 1 |
| Asoh, H | 1 |
| Ichinose, Y | 1 |
| Tsukamoto, S | 1 |
| Akaza, H | 4 |
| Yonekura, K | 6 |
| Basaki, Y | 6 |
| Chikahisa, L | 5 |
| Okabe, S | 5 |
| Hashimoto, A | 6 |
| Miyadera, K | 5 |
| Wierzba, K | 3 |
| Muraishi, O | 1 |
| Tokue, A | 1 |
| Fujinami, K | 1 |
| Kubota, Y | 1 |
| Shibata, J | 2 |
| Murakami, K | 1 |
| Fukushima, M | 1 |
| Aoyagi, K | 4 |
| Yano, A | 1 |
| Hashimoto, K | 1 |
| Okuchi, T | 1 |
| Mizoguchi, H | 1 |
| Mutaguchi, K | 1 |
| Nakamoto, T | 1 |
| Usui, T | 1 |
| Kitazato, K | 1 |
| Lea, MA | 1 |
| Koch, MR | 1 |
| Morris, HP | 1 |
| Nakada, J | 8 |
| Kondo, I | 5 |
| Furuta, N | 2 |
| Taguchi, H | 1 |
| Takaoka, K | 1 |
| Matsuda, M | 1 |
| Fujita, K | 1 |
| Munakata, A | 1 |
| Kameyama, S | 2 |
| Kanemura, M | 1 |
| Kitajima, K | 1 |
| Kawamura, T | 2 |
| Okada, K | 1 |
| Murahashi, I | 1 |
| Kawabe, K | 2 |
| Isurugi, K | 3 |
| Okumura, M | 1 |
| Asamoto, M | 1 |
| Ogiso, T | 1 |
| Ueda, T | 2 |
| Ohmori, A | 1 |
| Sakamoto, K | 1 |
| Aito, K | 1 |
| Morita, I | 1 |
| Ohta, Y | 1 |
| Takesue, T | 1 |
| Hara, S | 1 |
| Sato, K | 1 |
| Kayama, T | 1 |
| Sakurai, Y | 1 |
| Ogawa, A | 1 |
| Wada, T | 1 |
| Muramatsu, T | 1 |
| Hirata, N | 1 |
| Senda, H | 1 |
| Hara, M | 1 |
| Kawamura, N | 1 |
| Hasegawa, J | 1 |
| Fujioka, T | 1 |
| Hasegawa, M | 1 |
| Ishikura, K | 1 |
| Nomura, K | 1 |
| Okamoto, T | 1 |
| Tanji, S | 1 |
| Koike, H | 1 |
| Kubo, T | 1 |
| Mori, Y | 5 |
| Imai, K | 1 |
| Takahashi, H | 1 |
| Mashimo, T | 1 |
| Shimizu, N | 1 |
| Koya, J | 1 |
| Yajima, H | 1 |
| Kawashima, K | 1 |
| Kitaura, K | 1 |
| Kondo, N | 1 |
| Hongo, H | 1 |
| Nakayasu, K | 1 |
| Shinagawa, H | 1 |
| Ishizu, K | 1 |
| Misumi, K | 1 |
| Kuroda, Y | 1 |
| Kurata, S | 1 |
| Ohfuji, K | 1 |
| Suzuki, M | 5 |
| Mochizuki, A | 1 |
| Sugawara, T | 1 |
| Sakuramoto, T | 1 |
| Niijima, T | 2 |
| Aso, Y | 1 |
| Koiso, K | 1 |
| Yokoyama, M | 1 |
| Shoji, F | 1 |
| Matsuyama, H | 1 |
| Yamamoto, N | 1 |
| Sakatoku, J | 1 |
| Hara, Y | 1 |
| Sacho, T | 1 |
| Yasui, H | 1 |
| Ichikawa, T | 1 |
| Koshido, Y | 1 |
| Hayasida, S | 1 |
| Nagata, K | 1 |
| Nakagami, Y | 1 |
| Lin, TT | 1 |
| Ito, H | 1 |
| Hirasawa, S | 1 |
| Tannawa, K | 1 |
| Fujioka, Y | 1 |
| Ogawa, H | 1 |
| Tanaka, K | 1 |
| Yamada, N | 1 |
| Ishii, Y | 1 |
| Goto, A | 1 |
| Murai, T | 1 |
| Fukuoka, H | 1 |
| Kitamura, H | 1 |
| Yanase, I | 1 |
| Shirahama, T | 1 |
| Kayajima, T | 1 |
| Ohi, Y | 1 |
| Onishi, T | 2 |
| Furuta, M | 1 |
| Iizuka, N | 4 |
| Hoshino, M | 1 |
| Inoue, K | 1 |
| Higaki, M | 1 |
| Imamura, K | 1 |
| Ohnishi, T | 2 |
| Koseki, K | 1 |
| Kishi, H | 1 |
| Umeda, T | 1 |
| Mirvish, SS | 1 |
| Garcia, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Phase III Adjuvant Trial of High-Dose Bolus IL-2 in Patients With High-Risk Renal Cell Carcinoma[NCT00003126] | Phase 3 | 69 participants (Actual) | Interventional | 1997-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for uracil and Kidney Neoplasms
| Article | Year |
|---|---|
[Progress in oral anti-cancer drug therapy for urological cancer].
Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Drug Administration Sch | 1999 |
[A case of pulmonary metastasis from renal cell carcinoma with complete response to interferon-alpha and tegafur/uracil (UFT) but possibly UFT-induced liver dysfunction and leukoencephalopathy-like symptoms].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carcinoma, Renal Cell; Chemical and | 1999 |
[Combination chemotherapy with 5-FU and low-dose CDDP for urogenital tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Combined Modality | 1999 |
7 trials available for uracil and Kidney Neoplasms
| Article | Year |
|---|---|
[Clinical study of renal cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; | 1993 |
Phase II study of oral ftorafur and uracil in patients with advanced renal cell carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; Humans; Kidney | 1993 |
Postoperative UFT adjuvant and the risk factors for recurrence in renal cell carcinoma: a long-term follow-up study. Kyushu University Urological Oncology Group.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Drug Combinations; F | 1997 |
Adjuvant chemotherapy with vinblastine, adriamycin, and UFT for renal-cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Chemotherapy, Ad | 1992 |
[Treatment of renal cell carcinoma with human lymphoblastoid interferon alpha and UFT in combination. A prospective multicenter trial].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon Type I; Ki | 1991 |
[Clinical study of UFT chemotherapy in renal cancer. Kyushu University Cooperative Study Group of Renal Cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration | 1990 |
[Combination therapy of renal cell carcinoma with interferon-alpha and UFT (or FT-207)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modalit | 1989 |
51 other studies available for uracil and Kidney Neoplasms
| Article | Year |
|---|---|
[Renal Cancer after Spontaneous Rupture Successfully Treated with Low-Dose Oral UFT - A Case Report].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Humans; Kidney Diseases; Kidney N | 2018 |
Clinical outcome and prognostic survival factors in patients with advanced renal cell carcinoma treated with very low-dose interleukin-2, interferon-alpha, and tegafur-uracil: a single-institution experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Administrat | 2008 |
[Two cases of squamous cell carcinoma of upper urinary tract with hypercalcemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modali | 2008 |
[Tegafur-uracil markedly reduced pulmonary metastasis from renal cell carcinoma refractory to sorafenib, interferon and interleukin 2].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Renal Cell; Drug | 2010 |
[Renal transplantation surgery is closely linked with treatment for bilateral synchronous renal cell carcinomas or renal tumors in solitary kidney].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Combinations; Fema | 2004 |
[Pulmonary and lymph node metastases of renal cell carcinoma which completely responded to oral administration of UFT--a case report].
Topics: Administration, Oral; Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Drug Adm | 2007 |
[Clinical effect of UFT on urogenital tumors].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone an | 1984 |
[Phase II study of UFT for malignant tumors of urinary organs].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Comb | 1984 |
[Clinical experiences with UFD-1].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Combination | 1982 |
A case of posttherapeutic sclerotic change of bone metastasis from renal cell carcinoma which proved histopathologically to be complete response.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Renal Cell; Diagnostic Im | 1994 |
Initiation-stage enhancement by uracil of N-ethyl-N-hydroxyethylnitrosamine-induction of kidney carcinogenesis in rats.
Topics: Adenocarcinoma; Animals; Body Weight; Carcinogens; Diethylnitrosamine; Drug Synergism; Female; Kidne | 1994 |
Epithelia hyperplasia in the renal papilla and pelvis but not the urinary bladder of male F344 rats associated with dietary sodium phosphates after uracil exposure.
Topics: Animals; Drug Interactions; Epithelium; Hyperplasia; Kidney Medulla; Kidney Neoplasms; Kidney Pelvis | 1993 |
[Successful management for advanced renal cell carcinoma under combination therapy with human lymphoblastoid interferon-alpha and UFT (mixture of tegafur and uracil): a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Thera | 1993 |
[Long-term complete response of multiple lung metastases from renal cell carcinoma induced by combination therapy with interferon alpha and UFT: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon-alp | 1993 |
Strain and sex differences in kidney carcinogenesis in rats treated with N-ethyl-N-hydroxyethylnitrosamine and uracil.
Topics: Adenocarcinoma; Adenoma; Animals; Carcinogens; Diethylnitrosamine; Female; Kidney Neoplasms; Male; R | 1995 |
[Tumor reduction in advanced renal cell carcinoma with tumor thrombus by renal embolization, interferon-alpha and UFT. A case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Combinations; Embo | 1997 |
[Pulmonary metastasis from renal cell carcinoma diagnosed by using thoracoscopic biopsy: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Renal Cell; Female; Humans; | 1998 |
[Outpatient chemotherapy with oral UFT (tegafur and uracil) and cisplatin against metastatic non-small cell lung carcinoma--an effective case].
Topics: Administration, Oral; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bone Ne | 1999 |
UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.
Topics: 4-Butyrolactone; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cel | 1999 |
[Anti-metastatic and anti-angiogenic activity of UFT in a lung spontaneous metastasis model in mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Kidney Neoplasms; Lu | 1999 |
[Anti-angiogenic activities of UFT and its metabolites, GHB and GBL, in the dorsal air sac (DAS) model in mice].
Topics: 4-Butyrolactone; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Kidney Neo | 2000 |
UFT and its metabolites inhibit cancer-induced angiogenesis. Via a VEGF-related pathway.
Topics: Air Sacs; Animals; Antineoplastic Combined Chemotherapy Protocols; Biological Assay; Carcinoma, Rena | 2000 |
[Dihydropyrimidine dehydrogenase activity in urothelial cancer--influence of UFT administration on DPD activity].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehydrogenase | 2001 |
[Gamma-hydroxybutyric acid, a metabolite of UFT, shows anti-angiogenic activities and antitumor effect].
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Drug Combinations; Endothelial Growth Facto | 2002 |
gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
Topics: Angiogenesis Inhibitors; Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma; Carc | 2001 |
Decreased uptake of orotate in kidney tumors.
Topics: Animals; Kidney Cortex; Kidney Medulla; Kidney Neoplasms; Male; Neoplasms, Experimental; Orotic Acid | 1976 |
[A case of renal cell carcinoma with lung metastasis and local recurrence effectively treated with nephrectomy and UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; C | 1992 |
Concentration of 5-fluorouracil in renal cells from cancer patients administered a mixture of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Fluorouracil; Humans; Kidney; | 1991 |
[Adjuvant chemotherapy with vinblastine, adriamycin and UFT (VAU) for renal cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Doxorubicin; Drug Admin | 1991 |
Lack of synergism in rat urinary tract carcinogenesis between prior uracil treatment and N-butyl-N-(4-hydroxybutyl)-nitrosamine administration.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Cocarcinogenesis; Kidney Neoplasms; Kidney Pelvi | 1991 |
[A case of recurrence of a metastatic brain tumor which disappeared due to chemotherapy only].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Renal Cell; Humans; Kidn | 1990 |
[Various questions concerning the treatment of renal cell carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon Type I; Ki | 1990 |
[Combination chemotherapy of human renal cell carcinoma in athymic nude mice with human lymphoblastoid interferon (HLBI) and UFT, 5-Fu].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Th | 1990 |
[Therapy on pulmonary metastasis of renal cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Thera | 1990 |
[Antitumor activity of UFT against murine renal cell carcinoma: a study on the suppression tumor metastases].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Screening Assay | 1990 |
Efficacy of UFT for the treatment of renal cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; Humans; Kidney | 1989 |
[A case report of successful immunochemotherapy of metastatic renal cell carcinoma using UFT and PSK].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Clavicle; Humans; Kidne | 1987 |
[Complete regression of pulmonary metastasis from renal cell carcinoma following treatment with UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Hu | 1987 |
[Complete remission of lung metastasis of renal cell carcinoma by (UFT) therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Lun | 1987 |
[Collaborative study of UFT in far-advanced renal cell carcinoma. Urological Cooperative UFT Study Group].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug A | 1988 |
[Clinical study of UFT in far-advanced renal cell carcinoma].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; | 1988 |
[Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Carcinoma, Trans | 1987 |
[Complete remission of advanced renal cell carcinoma by chemotherapy and surgical treatment: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Combined Modality | 1987 |
[Antitumor activity of UFT and interferon-alpha against human renal cell carcinoma in athymic nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon T | 1988 |
[Anti-tumour effect of UFT on human renal cell carcinoma heterotransplanted into nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Division; Human | 1988 |
[Clinical effect of UFT in advanced renal cell carcinoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug | 1988 |
[Treatment of established human renal cell carcinoma--experimental treatment with interferon and UFT].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon T | 1988 |
[5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Fluorouracil; Humans; Kidney | 1985 |
[Clinical study of UFT in renal cell carcinoma].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Capsules; Carcinoma, Ren | 1985 |
[Effects of UFT in advanced renal cell cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; D | 1985 |
1-Nitroso-5, 6-dihydrouracil: induction of liver cell carcinomas and kidney adenomas in the rat.
Topics: Adenoma; Animals; Carcinoma, Hepatocellular; Female; Kidney Neoplasms; Lethal Dose 50; Liver Neoplas | 1973 |